BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 1 filers reported holding BENITEC BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,206 | -3.6% | 38,600 | -15.2% | 0.00% | – |
Q1 2023 | $9,550 | -84.8% | 45,500 | -87.7% | 0.00% | – |
Q4 2022 | $62,717 | +124.0% | 368,923 | +385.5% | 0.00% | – |
Q3 2022 | $28,000 | +300.0% | 75,994 | +1210.2% | 0.00% | – |
Q2 2022 | $7,000 | – | 5,800 | +5700.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
Q1 2021 | $438,000 | +1023.1% | 84,725 | +549.0% | 0.00% | – |
Q4 2020 | $39,000 | -82.2% | 13,054 | -62.5% | 0.00% | – |
Q3 2020 | $219,000 | -5.6% | 34,838 | +18.7% | 0.00% | – |
Q2 2020 | $232,000 | – | 29,338 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 796,837 | $296,000 | 1.76% |
Altium Capital Management LP | 658,796 | $245,000 | 0.09% |
CVI Holdings, LLC | 1,289,128 | $479,000 | 0.04% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $286,000 | 0.01% |
ARMISTICE CAPITAL, LLC | 1,555,039 | $578,000 | 0.01% |
FRANKLIN RESOURCES INC | 10,000,000 | $3,717,000 | 0.00% |
WealthTrust Axiom LLC | 12,950 | $4,000 | 0.00% |
CANTOR FITZGERALD, L. P. | 133,805 | $50,000 | 0.00% |
Walleye Capital LLC | 190,678 | $71,000 | 0.00% |
UBS Group AG | 28,683 | $11,000 | 0.00% |